The ParkinsonNet trial: Design and baseline characteristics
The companion paper describes how implementation of professional networks (ParkinsonNet) may improve the quality and efficiency of allied health care in Parkinson's disease (PD). We designed a cluster‐randomized controlled trial to evaluate this ParkinsonNet concept for one allied health discip...
Gespeichert in:
| Veröffentlicht in: | Movement disorders 2010-05, Vol.25 (7), p.830-837 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 837 |
|---|---|
| container_issue | 7 |
| container_start_page | 830 |
| container_title | Movement disorders |
| container_volume | 25 |
| creator | Keus, Samyra H. J. Nijkrake, Maarten J. Borm, George F. Kwakkel, Gert Roos, Raymund A. C. Berendse, Henk W. Adang, Eddy M. Overeem, Sebastiaan Bloem, Bastiaan R. Munneke, Marten |
| description | The companion paper describes how implementation of professional networks (ParkinsonNet) may improve the quality and efficiency of allied health care in Parkinson's disease (PD). We designed a cluster‐randomized controlled trial to evaluate this ParkinsonNet concept for one allied health discipline, namely physical therapy. Here we describe the study design and baseline characteristics. The design fully complies with the CONSORT criteria. Sixteen regions in the Netherlands were randomly divided into eight experimental regions where a ParkinsonNet was implemented, and eight control regions where the organization of care was left unchanged (usual care). Participating patients were followed for 6 months to evaluate the implementation process, health benefits and costs of the intervention. In the ParkinsonNet regions, 46 therapists were trained and 358 patients were included. In the usual care regions, 341 patients were included. Baseline characteristics of participants in the ParkinsonNet and control clusters were comparable. With 699 participating patients, this is the largest allied health study in PD to date. © 2010 Movement Disorder Society |
| doi_str_mv | 10.1002/mds.22815 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754551413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733511572</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4245-258cd926a52b56d54a0b98800b9671cb2f22841a8ceaff976ca533cf6e2a53ae3</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhi3UqmxpD_wBlEuFegj4a2KnnBAUClooCKoerYkzKW6zWWpn1fLvcbsLnBAX24dn3pl5zNim4DuCc7k7a9OOlFbAGpsIUKK0EswrNuHWQqmEhXX2NqWfnAsBonrD1iXXlTB1PWF71zdUXGD8FYY0H85pLMYYsP9UHFIKP4YCh7ZoMFEfBir8DUb0I8WQxuDTO_a6wz7R-9W9wb4dfb4--FJOvx6fHOxPS6-lhlKC9W0tKwTZQNWCRt7U1vJ8Vkb4RnZ5di3QesKuq03lEZTyXUUyP5DUBtte5t7G-e8FpdHNQvLU9zjQfJGcAQ0gtFAvk0pBdmBkJj8uSR_nKUXq3G0MM4x3TnD3T6rLUt1_qZndWqUumhm1j-SDxQx8WAGYPPZdxMGH9MTl9YyWPHO7S-5P6Onu-Y7u7PDqoXW5rMjG6e9jRf4vVxllwH0_P3aXUp9eTi9O3Zm6B3OFm1k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733511572</pqid></control><display><type>article</type><title>The ParkinsonNet trial: Design and baseline characteristics</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Keus, Samyra H. J. ; Nijkrake, Maarten J. ; Borm, George F. ; Kwakkel, Gert ; Roos, Raymund A. C. ; Berendse, Henk W. ; Adang, Eddy M. ; Overeem, Sebastiaan ; Bloem, Bastiaan R. ; Munneke, Marten</creator><creatorcontrib>Keus, Samyra H. J. ; Nijkrake, Maarten J. ; Borm, George F. ; Kwakkel, Gert ; Roos, Raymund A. C. ; Berendse, Henk W. ; Adang, Eddy M. ; Overeem, Sebastiaan ; Bloem, Bastiaan R. ; Munneke, Marten ; ParkinsonNet Trial Study Group ; on behalf of the ParkinsonNet Trial Study Group</creatorcontrib><description>The companion paper describes how implementation of professional networks (ParkinsonNet) may improve the quality and efficiency of allied health care in Parkinson's disease (PD). We designed a cluster‐randomized controlled trial to evaluate this ParkinsonNet concept for one allied health discipline, namely physical therapy. Here we describe the study design and baseline characteristics. The design fully complies with the CONSORT criteria. Sixteen regions in the Netherlands were randomly divided into eight experimental regions where a ParkinsonNet was implemented, and eight control regions where the organization of care was left unchanged (usual care). Participating patients were followed for 6 months to evaluate the implementation process, health benefits and costs of the intervention. In the ParkinsonNet regions, 46 therapists were trained and 358 patients were included. In the usual care regions, 341 patients were included. Baseline characteristics of participants in the ParkinsonNet and control clusters were comparable. With 699 participating patients, this is the largest allied health study in PD to date. © 2010 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.22815</identifier><identifier>PMID: 20461799</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Aged ; Allied Health Personnel ; Biological and medical sciences ; cluster analysis ; community networks ; Disability Evaluation ; Drug Therapy - statistics & numerical data ; guideline adherence ; Hospitals, General - statistics & numerical data ; Humans ; Male ; Medical sciences ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology ; Neurology - manpower ; Neurology - statistics & numerical data ; Parkinson disease ; Parkinson Disease - drug therapy ; Parkinson Disease - epidemiology ; Parkinson Disease - therapy ; physical therapy ; Physical Therapy Modalities ; Practice Guidelines as Topic ; Quality of Life - psychology ; Recovery of Function ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome</subject><ispartof>Movement disorders, 2010-05, Vol.25 (7), p.830-837</ispartof><rights>Copyright © 2010 Movement Disorder Society</rights><rights>2015 INIST-CNRS</rights><rights>(c) 2010 Movement Disorder Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4245-258cd926a52b56d54a0b98800b9671cb2f22841a8ceaff976ca533cf6e2a53ae3</citedby><cites>FETCH-LOGICAL-c4245-258cd926a52b56d54a0b98800b9671cb2f22841a8ceaff976ca533cf6e2a53ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.22815$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.22815$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22847420$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20461799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keus, Samyra H. J.</creatorcontrib><creatorcontrib>Nijkrake, Maarten J.</creatorcontrib><creatorcontrib>Borm, George F.</creatorcontrib><creatorcontrib>Kwakkel, Gert</creatorcontrib><creatorcontrib>Roos, Raymund A. C.</creatorcontrib><creatorcontrib>Berendse, Henk W.</creatorcontrib><creatorcontrib>Adang, Eddy M.</creatorcontrib><creatorcontrib>Overeem, Sebastiaan</creatorcontrib><creatorcontrib>Bloem, Bastiaan R.</creatorcontrib><creatorcontrib>Munneke, Marten</creatorcontrib><creatorcontrib>ParkinsonNet Trial Study Group</creatorcontrib><creatorcontrib>on behalf of the ParkinsonNet Trial Study Group</creatorcontrib><title>The ParkinsonNet trial: Design and baseline characteristics</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>The companion paper describes how implementation of professional networks (ParkinsonNet) may improve the quality and efficiency of allied health care in Parkinson's disease (PD). We designed a cluster‐randomized controlled trial to evaluate this ParkinsonNet concept for one allied health discipline, namely physical therapy. Here we describe the study design and baseline characteristics. The design fully complies with the CONSORT criteria. Sixteen regions in the Netherlands were randomly divided into eight experimental regions where a ParkinsonNet was implemented, and eight control regions where the organization of care was left unchanged (usual care). Participating patients were followed for 6 months to evaluate the implementation process, health benefits and costs of the intervention. In the ParkinsonNet regions, 46 therapists were trained and 358 patients were included. In the usual care regions, 341 patients were included. Baseline characteristics of participants in the ParkinsonNet and control clusters were comparable. With 699 participating patients, this is the largest allied health study in PD to date. © 2010 Movement Disorder Society</description><subject>Aged</subject><subject>Allied Health Personnel</subject><subject>Biological and medical sciences</subject><subject>cluster analysis</subject><subject>community networks</subject><subject>Disability Evaluation</subject><subject>Drug Therapy - statistics & numerical data</subject><subject>guideline adherence</subject><subject>Hospitals, General - statistics & numerical data</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><subject>Neurology - manpower</subject><subject>Neurology - statistics & numerical data</subject><subject>Parkinson disease</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - epidemiology</subject><subject>Parkinson Disease - therapy</subject><subject>physical therapy</subject><subject>Physical Therapy Modalities</subject><subject>Practice Guidelines as Topic</subject><subject>Quality of Life - psychology</subject><subject>Recovery of Function</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhi3UqmxpD_wBlEuFegj4a2KnnBAUClooCKoerYkzKW6zWWpn1fLvcbsLnBAX24dn3pl5zNim4DuCc7k7a9OOlFbAGpsIUKK0EswrNuHWQqmEhXX2NqWfnAsBonrD1iXXlTB1PWF71zdUXGD8FYY0H85pLMYYsP9UHFIKP4YCh7ZoMFEfBir8DUb0I8WQxuDTO_a6wz7R-9W9wb4dfb4--FJOvx6fHOxPS6-lhlKC9W0tKwTZQNWCRt7U1vJ8Vkb4RnZ5di3QesKuq03lEZTyXUUyP5DUBtte5t7G-e8FpdHNQvLU9zjQfJGcAQ0gtFAvk0pBdmBkJj8uSR_nKUXq3G0MM4x3TnD3T6rLUt1_qZndWqUumhm1j-SDxQx8WAGYPPZdxMGH9MTl9YyWPHO7S-5P6Onu-Y7u7PDqoXW5rMjG6e9jRf4vVxllwH0_P3aXUp9eTi9O3Zm6B3OFm1k</recordid><startdate>20100515</startdate><enddate>20100515</enddate><creator>Keus, Samyra H. J.</creator><creator>Nijkrake, Maarten J.</creator><creator>Borm, George F.</creator><creator>Kwakkel, Gert</creator><creator>Roos, Raymund A. C.</creator><creator>Berendse, Henk W.</creator><creator>Adang, Eddy M.</creator><creator>Overeem, Sebastiaan</creator><creator>Bloem, Bastiaan R.</creator><creator>Munneke, Marten</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20100515</creationdate><title>The ParkinsonNet trial: Design and baseline characteristics</title><author>Keus, Samyra H. J. ; Nijkrake, Maarten J. ; Borm, George F. ; Kwakkel, Gert ; Roos, Raymund A. C. ; Berendse, Henk W. ; Adang, Eddy M. ; Overeem, Sebastiaan ; Bloem, Bastiaan R. ; Munneke, Marten</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4245-258cd926a52b56d54a0b98800b9671cb2f22841a8ceaff976ca533cf6e2a53ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Allied Health Personnel</topic><topic>Biological and medical sciences</topic><topic>cluster analysis</topic><topic>community networks</topic><topic>Disability Evaluation</topic><topic>Drug Therapy - statistics & numerical data</topic><topic>guideline adherence</topic><topic>Hospitals, General - statistics & numerical data</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><topic>Neurology - manpower</topic><topic>Neurology - statistics & numerical data</topic><topic>Parkinson disease</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - epidemiology</topic><topic>Parkinson Disease - therapy</topic><topic>physical therapy</topic><topic>Physical Therapy Modalities</topic><topic>Practice Guidelines as Topic</topic><topic>Quality of Life - psychology</topic><topic>Recovery of Function</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keus, Samyra H. J.</creatorcontrib><creatorcontrib>Nijkrake, Maarten J.</creatorcontrib><creatorcontrib>Borm, George F.</creatorcontrib><creatorcontrib>Kwakkel, Gert</creatorcontrib><creatorcontrib>Roos, Raymund A. C.</creatorcontrib><creatorcontrib>Berendse, Henk W.</creatorcontrib><creatorcontrib>Adang, Eddy M.</creatorcontrib><creatorcontrib>Overeem, Sebastiaan</creatorcontrib><creatorcontrib>Bloem, Bastiaan R.</creatorcontrib><creatorcontrib>Munneke, Marten</creatorcontrib><creatorcontrib>ParkinsonNet Trial Study Group</creatorcontrib><creatorcontrib>on behalf of the ParkinsonNet Trial Study Group</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keus, Samyra H. J.</au><au>Nijkrake, Maarten J.</au><au>Borm, George F.</au><au>Kwakkel, Gert</au><au>Roos, Raymund A. C.</au><au>Berendse, Henk W.</au><au>Adang, Eddy M.</au><au>Overeem, Sebastiaan</au><au>Bloem, Bastiaan R.</au><au>Munneke, Marten</au><aucorp>ParkinsonNet Trial Study Group</aucorp><aucorp>on behalf of the ParkinsonNet Trial Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The ParkinsonNet trial: Design and baseline characteristics</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>2010-05-15</date><risdate>2010</risdate><volume>25</volume><issue>7</issue><spage>830</spage><epage>837</epage><pages>830-837</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>The companion paper describes how implementation of professional networks (ParkinsonNet) may improve the quality and efficiency of allied health care in Parkinson's disease (PD). We designed a cluster‐randomized controlled trial to evaluate this ParkinsonNet concept for one allied health discipline, namely physical therapy. Here we describe the study design and baseline characteristics. The design fully complies with the CONSORT criteria. Sixteen regions in the Netherlands were randomly divided into eight experimental regions where a ParkinsonNet was implemented, and eight control regions where the organization of care was left unchanged (usual care). Participating patients were followed for 6 months to evaluate the implementation process, health benefits and costs of the intervention. In the ParkinsonNet regions, 46 therapists were trained and 358 patients were included. In the usual care regions, 341 patients were included. Baseline characteristics of participants in the ParkinsonNet and control clusters were comparable. With 699 participating patients, this is the largest allied health study in PD to date. © 2010 Movement Disorder Society</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20461799</pmid><doi>10.1002/mds.22815</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-3185 |
| ispartof | Movement disorders, 2010-05, Vol.25 (7), p.830-837 |
| issn | 0885-3185 1531-8257 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_754551413 |
| source | MEDLINE; Wiley Online Library |
| subjects | Aged Allied Health Personnel Biological and medical sciences cluster analysis community networks Disability Evaluation Drug Therapy - statistics & numerical data guideline adherence Hospitals, General - statistics & numerical data Humans Male Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Neurology - manpower Neurology - statistics & numerical data Parkinson disease Parkinson Disease - drug therapy Parkinson Disease - epidemiology Parkinson Disease - therapy physical therapy Physical Therapy Modalities Practice Guidelines as Topic Quality of Life - psychology Recovery of Function Surveys and Questionnaires Time Factors Treatment Outcome |
| title | The ParkinsonNet trial: Design and baseline characteristics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A33%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20ParkinsonNet%20trial:%20Design%20and%20baseline%20characteristics&rft.jtitle=Movement%20disorders&rft.au=Keus,%20Samyra%20H.%20J.&rft.aucorp=ParkinsonNet%20Trial%20Study%20Group&rft.date=2010-05-15&rft.volume=25&rft.issue=7&rft.spage=830&rft.epage=837&rft.pages=830-837&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.22815&rft_dat=%3Cproquest_cross%3E733511572%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733511572&rft_id=info:pmid/20461799&rfr_iscdi=true |